Please login to the form below

Not currently logged in
Email:
Password:

Puma

This page shows the latest Puma news and features for those working in and with pharma, biotech and healthcare.

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Paediatric use drugs. During its four-day meeting, the CHMP approved two new paediatric-use marketing authorisations (PUMAs) for off-patent drugs specifically developed for use in children. ... Kigabeq (vigabatrin), the other PUMA medicine, has been

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Constellation Pharmaceuticals strengthens management team Constellation Pharmaceuticals strengthens management team

    Senderowicz has over 20 years’ experience in the life sciences sector, with his most recent role seeing him sit on Puma Biotechnology’s board of directors. ... Prior to his time at Puma, Senderowicz held several roles for the life sciences sector

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics